bicalutamide
Bicalutamide was patented in 1982 and approved for medical use in 1995. It is sold under the brand name Casodex among others, is an antiandrogen medication that is primarily used to treat prostate cancer.. Reference standards of Bicalutamide API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object
(
[pname] => Bicalutamide-d4 O-β-D-Glucuronide
[catalogue_number] => PA STI 012740
[category_ids] => ,80,95,76,75,78,70,82,88,98,
[chemical_name] =>
[weight] => 610.52
[form] => C24H18D4F4N2O10S
[cas] => NA
[pslug] => bicalutamide-d4-o-beta-d-glucuronide-pasti012740
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Bicalutamide-d4 O-β-D-Glucuronide
Catalogue No.:PA STI 012740
Molecular Formula : C24H18D4F4N2O10S
Molecular Weight : 610.52